News: Articles and Publications

The Gates Medical Research Institute (MRI) today announced the appointment of Charles Wells, MD, as Chief Medical Officer (CMO) and Head of Medical Development, effective May 15, 2026.

Krishnan (Krish) Ramanathan, who has served as Chief of Staff and Head of Development at Gates Medical Research Institute (MRI), has been named Interim Chief Executive Officer (CEO) of the organization.

We’re glad to announce that the Phase 3 clinical trial of the M72/AS01E tuberculosis (TB) vaccine candidate has reached full enrollment eleven months ahead of schedule– with approximately 20,000 participants enrolled.

For more information, contact: media@gatesmri.org Cambridge, Mass., USA (28 May 2024) — The Bill & Melinda Gates Medical Research Institute (Gates MRI) today announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer (CEO), starting June 10, 2024. He succeeds the current CEO, Emilio Emini, PhD, who recently announced his retirement, effective on June 30, 2024. Dr. Matchaba began his career as a physician in South Africa before working for more than two decades in the pharmaceutical industry. In his time with Novartis Global Pharmaceuticals in the US and Switzerland, Dr. Matchaba gained expertise in drug development, global product registration, and market access. Prior to joining the institute, his most recent roles were President of Novartis’ U.S. Foundation and Novartis Group Head of Global Health. Before joining…